{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:47:41Z","timestamp":1767977261934,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"American Society of Nephrology and National Institute of Allergy and Infectious Diseases","award":["1K23AI139335"],"award-info":[{"award-number":["1K23AI139335"]}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes And Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007180"],"award-info":[{"award-number":["T32DK007180"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00467-023-06055-0","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T07:02:06Z","timestamp":1689058926000},"page":"4175-4185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Angiotensin II type 1 receptor antibodies and native kidney function in pediatric liver and intestinal transplant recipients"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8028-9582","authenticated-orcid":false,"given":"Rachel","family":"Stern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"6055_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1056\/NEJMoa035717","volume":"352","author":"D Dragun","year":"2005","unstructured":"Dragun D, M\u00fcller DN, Br\u00e4sen JH, Fritsche L, Nieminen-Kelh\u00e4 M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I (2005) Angiotensin II Type 1\u2013Receptor Activating Antibodies in Renal-Allograft Rejection. N Engl J Med 352:558\u2013569. https:\/\/doi.org\/10.1056\/NEJMoa035717","journal-title":"N Engl J Med"},{"key":"6055_CR2","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1097\/01.TP.0000163290.19788.E7","volume":"79","author":"Q Sun","year":"2005","unstructured":"Sun Q, Liu Z, Yin G, Chen J, Li L (2005) Detectable Circulating Antiendothelial Cell Antibodies in Renal Allograft Recipients with C4d-Positive Acute Rejection: A Report of Three Cases. Transplantation 79:1759\u20131762. https:\/\/doi.org\/10.1097\/01.TP.0000163290.19788.E7","journal-title":"Transplantation"},{"key":"6055_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","volume":"21","author":"P Dandona","year":"2007","unstructured":"Dandona P, Dhindsa S, Ghanim H, Chaudhuri A (2007) Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens 21:20\u201327. https:\/\/doi.org\/10.1038\/sj.jhh.1002101","journal-title":"J Hum Hypertens"},{"key":"6055_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","volume":"86","author":"M Ruiz-Ortega","year":"2000","unstructured":"Ruiz-Ortega M, Lorenzo O, Rup\u00e9rez M, Konig S, Wittig B, Egido J (2000) Angiotensin II Activates Nuclear Transcription Factor \u03baB Through AT 1 and AT 2 in Vascular Smooth Muscle Cells: Molecular Mechanisms. Circ Res 86:1266\u20131272. https:\/\/doi.org\/10.1161\/01.RES.86.12.1266","journal-title":"Circ Res"},{"key":"6055_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.kint.2019.01.030","volume":"96","author":"C Lefaucheur","year":"2019","unstructured":"Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A (2019) Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients. Kidney Int 96:189\u2013201. https:\/\/doi.org\/10.1016\/j.kint.2019.01.030","journal-title":"Kidney Int"},{"key":"6055_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/petr.12728","volume":"20","author":"A Bjerre","year":"2016","unstructured":"Bjerre A, Tangeraas T, Heidecke H, Dragun D, Dechend R, Staff AC (2016) Angiotensin II type 1 receptor antibodies in childhood kidney transplantation. Pediatr Transplant 20:627\u2013632. https:\/\/doi.org\/10.1111\/petr.12728","journal-title":"Pediatr Transplant"},{"key":"6055_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/ndt\/gfab344","volume":"37","author":"Z-Y Kang","year":"2022","unstructured":"Kang Z-Y, Liu C, Liu W, Li D-H (2022) Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant 37:1171\u20131180. https:\/\/doi.org\/10.1093\/ndt\/gfab344","journal-title":"Nephrol Dial Transplant"},{"key":"6055_CR8","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1111\/ajt.12397","volume":"13","author":"M Giral","year":"2013","unstructured":"Giral M, Foucher Y, Dufay A, Van Huyen JD, Renaudin K, Moreau A, Philippe A, Hegner B, Dechend R, Heidecke H, Brouard S (2013) Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant 13:2567\u20132576. https:\/\/doi.org\/10.1111\/ajt.12397","journal-title":"Am J Transplant"},{"key":"6055_CR9","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.transproceed.2014.09.029","volume":"46","author":"M Banasik","year":"2014","unstructured":"Banasik M, Boraty\u0144ska M, Ko\u015bcielska-Kasprzak K, Kami\u0144ska D, Zmonarski S, Mazanowska O, Krajewska M, Bartoszek D, \u017babi\u0144ska M, Myszka M, Kami\u0144ska M (2014) Non-HLA Antibodies: Angiotensin II Type 1 Receptor (Anti-AT1R) and Endothelin-1 Type A Receptor (Anti-ETAR) Are Associated With Renal Allograft Injury and Graft Loss. Transplant Proc 46:2618\u20132621. https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.029","journal-title":"Transplant Proc"},{"key":"6055_CR10","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.trim.2022.101674","volume":"74","author":"C Liu","year":"2022","unstructured":"Liu C, Kang Z-Y, Yin Z, Xiao Y, Liu W, Zhao Y, Li DH (2022) Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients. Transpl Immunol 74:101674. https:\/\/doi.org\/10.1016\/j.trim.2022.101674","journal-title":"Transpl Immunol"},{"key":"6055_CR11","doi-asserted-by":"publisher","first-page":"809059","DOI":"10.3389\/fimmu.2022.809059","volume":"13","author":"A Senev","year":"2022","unstructured":"Senev A, Ray B, Lerut E, Hariharan J, Heylen C, Kuypers D, Sprangers B, Emonds MP, Naesens M (2022) The Pre-Transplant Non-HLA Antibody Burden Associates With the Development of Histology of Antibody-Mediated Rejection After Kidney Transplantation. Front Immunol 13:809059. https:\/\/doi.org\/10.3389\/fimmu.2022.809059","journal-title":"Front Immunol"},{"key":"6055_CR12","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1111\/ajt.12395","volume":"13","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT, Kendrick SA (2013) Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant 13:2577\u20132589. https:\/\/doi.org\/10.1111\/ajt.12395","journal-title":"Am J Transplant"},{"key":"6055_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.kint.2017.06.034","volume":"93","author":"MH Pearl","year":"2018","unstructured":"Pearl MH, Zhang Q, Palma Diaz MF, Grotts J, Rossetti M, Elashoff D, Gjertson DW, Weng P, Reed EF, Chambers ET (2018) Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. Kidney Int 93:260\u2013269. https:\/\/doi.org\/10.1016\/j.kint.2017.06.034","journal-title":"Kidney Int"},{"key":"6055_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/petr.12531","volume":"19","author":"LE Hesemann","year":"2015","unstructured":"Hesemann LE, Subramanian V, Mohanakumar T, Dharnidharka VR (2015) De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children. Pediatr Transplant 19:499\u2013503. https:\/\/doi.org\/10.1111\/petr.12531","journal-title":"Pediatr Transplant"},{"key":"6055_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/ndt\/gfy008","volume":"33","author":"A Fichtner","year":"2018","unstructured":"Fichtner A, S\u00fcsal C, Schr\u00f6der C, H\u00f6cker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, T\u00f6nshoff B (2018) Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients. Nephrol Dial Transplant 33:1065\u20131072. https:\/\/doi.org\/10.1093\/ndt\/gfy008","journal-title":"Nephrol Dial Transplant"},{"key":"6055_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ekir.2018.12.011","volume":"4","author":"MH Pearl","year":"2019","unstructured":"Pearl MH, Grotts J, Rossetti M, Zhang Q, Gjertson DW, Weng P, Elashoff D, Reed EF, Chambers ET (2019) Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies. Kidney Int Rep 4:541\u2013550. https:\/\/doi.org\/10.1016\/j.ekir.2018.12.011","journal-title":"Kidney Int Rep"},{"key":"6055_CR17","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.healun.2021.01.1820","volume":"40","author":"JA Spinner","year":"2021","unstructured":"Spinner JA, Philogene M, Nicholas S, Jindra P, Choudhry S, Hope KD, Puri K, Tunuguntla HP, Price J, Denfield SW, Dreyer WJ (2021) AT1R-Ab: A New Player in Pediatric Heart Transplant AMR? J Heart Lung Transplant 40:S33. https:\/\/doi.org\/10.1016\/j.healun.2021.01.1820","journal-title":"J Heart Lung Transplant"},{"key":"6055_CR18","doi-asserted-by":"publisher","first-page":"e13987","DOI":"10.1111\/petr.13987","volume":"25","author":"AP Chan","year":"2021","unstructured":"Chan AP, Guerra MR, Rossetti M, Hickey MJ, Venick RS, Marcus EA, McDiarmid SV, Farmer DG, Reed EF, Wozniak LJ (2021) Non-HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation. Pediatr Transplant 25:e13987. https:\/\/doi.org\/10.1111\/petr.13987","journal-title":"Pediatr Transplant"},{"key":"6055_CR19","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1097\/TP.0000000000003206","volume":"104","author":"LJ Wozniak","year":"2020","unstructured":"Wozniak LJ, Hickey MJ, Chan AP, Venick RS, Farmer DG, Busuttil RW, Reed EF, McDiarmid SV (2020) Angiotensin II Type-1 Receptor Antibodies Are Associated With Active Allograft Dysfunction Following Pediatric Liver Transplantation. Transplantation 104:2547\u20132556. https:\/\/doi.org\/10.1097\/TP.0000000000003206","journal-title":"Transplantation"},{"key":"6055_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","volume":"98","author":"H Ohe","year":"2014","unstructured":"Ohe H, Uchida Y, Yoshizawa A, Hirao H, Taniguchi M, Maruya E, Yurugi K, Hishida R, Maekawa T, Uemoto S, Terasaki PI (2014) Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal. Transplantation 98:1105\u20131111. https:\/\/doi.org\/10.1097\/TP.0000000000000185","journal-title":"Transplantation"},{"key":"6055_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1111\/ajt.14638","volume":"18","author":"C Williams","year":"2018","unstructured":"Williams C, Borges K, Banh T, Vasilevska-Ristovska J, Chanchlani R, Ng VL, Dipchand AI, Solomon M, Hebert D, Kim SJ, Astor BC (2018) Patterns of kidney injury in pediatric nonkidney solid organ transplant recipients. Am J Transplant 18:1481\u20131488. https:\/\/doi.org\/10.1111\/ajt.14638","journal-title":"Am J Transplant"},{"key":"6055_CR22","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1681\/ASN.2007040394","volume":"18","author":"RD Bloom","year":"2007","unstructured":"Bloom RD, Reese PP (2007) Chronic Kidney Disease after Nonrenal Solid-Organ Transplantation. J Am Soc Nephrol 18:3031\u20133041. https:\/\/doi.org\/10.1681\/ASN.2007040394","journal-title":"J Am Soc Nephrol"},{"key":"6055_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMoa021744","volume":"349","author":"AO Ojo","year":"2003","unstructured":"Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931\u2013940. https:\/\/doi.org\/10.1056\/NEJMoa021744","journal-title":"N Engl J Med"},{"key":"6055_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ehf2.12585","volume":"7","author":"S Roest","year":"2020","unstructured":"Roest S, Hesselink DA, Klimczak-Tomaniak D, Kardys I, Caliskan K, Brugts JJ, Maat AP, Ciszek M, Constantinescu AA, Manintveld OC (2020) Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival. ESC Heart Fail 7:533\u2013541. https:\/\/doi.org\/10.1002\/ehf2.12585","journal-title":"ESC Heart Fail"},{"key":"6055_CR25","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.3390\/jcm9082455","volume":"9","author":"T-J Wang","year":"2020","unstructured":"Wang T-J, Lin C-H, Wei H-J, Wu M-J (2020) Long-Term Outcomes and Risk Factors of Renal Failure Requiring Dialysis after Heart Transplantation: A Nationwide Cohort Study. J Clin Med 9:2455. https:\/\/doi.org\/10.3390\/jcm9082455","journal-title":"J Clin Med"},{"key":"6055_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/lt.25694","volume":"26","author":"G Cullaro","year":"2020","unstructured":"Cullaro G, Verna EC, Lee BP, Lai JC (2020) Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post-Liver Transplant Outcomes. Liver Transpl 26:498\u2013506. https:\/\/doi.org\/10.1002\/lt.25694","journal-title":"Liver Transpl"},{"key":"6055_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.transproceed.2021.01.013","volume":"53","author":"JG O\u2019Leary","year":"2021","unstructured":"O\u2019Leary JG, Philippe A, Freeman R, Heidecke H, Jennings LW, Catar R, Klintmalm GB, Dragun D (2021) Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients. Transplant Proc 53:1019\u20131024. https:\/\/doi.org\/10.1016\/j.transproceed.2021.01.013","journal-title":"Transplant Proc"},{"key":"6055_CR28","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1038\/s41598-019-55550-8","volume":"9","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Cui H, Lv J, Liang H, Zheng Y, Wang S, Wang M, Wang H, Ye F (2019) AT1 and AT2 receptors modulate renal tubular cell necroptosis in angiotensin II-infused renal injury mice. Sci Rep 9:19450. https:\/\/doi.org\/10.1038\/s41598-019-55550-8","journal-title":"Sci Rep"},{"key":"6055_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00467-016-3500-8","volume":"32","author":"I Guzzo","year":"2017","unstructured":"Guzzo I, Morolli F, Camassei FD, Piazza A, Poggi E, Dello Strologo L (2017) Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient. Pediatr Nephrol 32:185\u2013188. https:\/\/doi.org\/10.1007\/s00467-016-3500-8","journal-title":"Pediatr Nephrol"},{"key":"6055_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.humimm.2015.07.025","volume":"76","author":"JH Lan","year":"2015","unstructured":"Lan JH, Zhang Q, Reed EF, Reddy U (2015) OR19 Successful reversal of severe kidney allograft rejection mediated by angiotensin II type 1-receptor antibodies. Hum Immunol 76:17. https:\/\/doi.org\/10.1016\/j.humimm.2015.07.025","journal-title":"Hum Immunol"},{"key":"6055_CR31","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.humimm.2016.08.009","volume":"77","author":"RP Carroll","year":"2016","unstructured":"Carroll RP, Riceman M, Hope CM, Zeng A, Deayton S, Bennett GD, Coates PT (2016) Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan. Hum Immunol 77:1154\u20131158. https:\/\/doi.org\/10.1016\/j.humimm.2016.08.009","journal-title":"Hum Immunol"},{"key":"6055_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Mu\u00f1oz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956. https:\/\/doi.org\/10.1016\/j.kint.2020.10.047","journal-title":"Kidney Int"},{"key":"6055_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"6055_CR34","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2215\/CJN.05900611","volume":"6","author":"JJ Fadrowski","year":"2011","unstructured":"Fadrowski JJ, Furth SL (2011) GFR Estimation in Children: Questions and Answers (and Questions). Clin J Am Soc Nephrol 6:1810\u20131812. https:\/\/doi.org\/10.2215\/CJN.05900611","journal-title":"Clin J Am Soc Nephrol"},{"key":"6055_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.ki.5000032","volume":"69","author":"DJ Askenazi","year":"2006","unstructured":"Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL (2006) 3\u20135 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184\u2013189. https:\/\/doi.org\/10.1038\/sj.ki.5000032","journal-title":"Kidney Int"},{"key":"6055_CR36","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS (2017) Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 140:e20171904. https:\/\/doi.org\/10.1542\/peds.2017-1904","journal-title":"Pediatrics"},{"key":"6055_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59:251\u2013287. https:\/\/doi.org\/10.1124\/pr.59.3.3","journal-title":"Pharmacol Rev"},{"key":"6055_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/TP.0000000000001439","volume":"101","author":"UA Gerlach","year":"2017","unstructured":"Gerlach UA, Lachmann N, Ranucci G, Sawitzki B, Schoenemann C, Pratschke J, Dragun D, Pascher A (2017) Non-HLA Antibodies May Accelerate Immune Responses After Intestinal and Multivisceral Transplantation. Transplantation 101:141\u2013149. https:\/\/doi.org\/10.1097\/TP.0000000000001439","journal-title":"Transplantation"},{"key":"6055_CR39","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME (2021) New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med 385:1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"6055_CR40","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/ncpneph0765","volume":"4","author":"D Kniepeiss","year":"2008","unstructured":"Kniepeiss D, Stiegler P, Roller RE, Groselj-Strele A, Wirnsberger G (2008) Cystatin C has prognostic value after liver transplantation. Nat Clin Pract Nephrol 4:E1\u2013E1. https:\/\/doi.org\/10.1038\/ncpneph0765","journal-title":"Nat Clin Pract Nephrol"},{"key":"6055_CR41","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/archinte.1988.00380060077017","volume":"148","author":"T Takabatake","year":"1988","unstructured":"Takabatake T, Ohta H, Ishida Y, Hara H, Ushiogi Y, Hattori N (1988) Low serum creatinine levels in severe hepatic disease. Arch Intern Med 148:1313\u20131315","journal-title":"Arch Intern Med"},{"key":"6055_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.ackd.2015.05.003","volume":"22","author":"T Beben","year":"2015","unstructured":"Beben T, Rifkin DE (2015) GFR Estimating Equations and Liver Disease. Adv Chronic Kidney Dis 22:337\u2013342. https:\/\/doi.org\/10.1053\/j.ackd.2015.05.003","journal-title":"Adv Chronic Kidney Dis"},{"key":"6055_CR43","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1681\/ASN.2008070730","volume":"20","author":"SI Hallan","year":"2009","unstructured":"Hallan SI, Ritz E, Lydersen S, Kvenild K, Orth SR (2009) Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 20:1069\u20131077. https:\/\/doi.org\/10.1681\/ASN.2008070730","journal-title":"J Am Soc Nephrol"},{"key":"6055_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.kint.2016.03.019","volume":"90","author":"D Dragun","year":"2016","unstructured":"Dragun D, Catar R, Philippe A (2016) Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity. Kidney Int 90:280\u2013288. https:\/\/doi.org\/10.1016\/j.kint.2016.03.019","journal-title":"Kidney Int"},{"key":"6055_CR45","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1097\/TP.0000000000001853","volume":"101","author":"JG O\u2019Leary","year":"2017","unstructured":"O\u2019Leary JG, Demetris AJ, Philippe A, Freeman R, Cai J, Heidecke H, Smith C, Hart B, Jennings LW, Catar R, Everly M (2017) Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts. Transplantation 101:2399\u20132409. https:\/\/doi.org\/10.1097\/TP.0000000000001853","journal-title":"Transplantation"},{"key":"6055_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/children8080633","volume":"8","author":"G Kowalewski","year":"2021","unstructured":"Kowalewski G, Kalici\u0144ski P, Stefanowicz M, Grenda R, Czubkowski P, Szymczak M (2021) Long-Term Follow-Up of Renal Function in Children after Liver Transplantation-A Single Center Retrospective Study. Child (Basel) 8:633. https:\/\/doi.org\/10.3390\/children8080633","journal-title":"Child (Basel)"},{"key":"6055_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004465","volume-title":"Late-onset Chronic Kidney Disease Over 2 Decades After Pediatric Liver Transplantation: A Single-center","author":"K Umemura","year":"2023","unstructured":"Umemura K, Mita A, Ohno Y, Masuda Y, Yoshizawa K, Kubota K, Notake T, Hosoda K, Kamachi A, Goto T, Tomida H (2023) Late-onset Chronic Kidney Disease Over 2 Decades After Pediatric Liver Transplantation: A Single-center, Retrospective Study. Transplantation 107:1535-1544. https:\/\/doi.org\/10.1097\/TP.0000000000004465"},{"key":"6055_CR48","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/clc.20852","volume":"34","author":"F Zhu","year":"2011","unstructured":"Zhu F, Sun Y, Wang M, Ma S, Chen X, Cao A, Chen F, Qiu Y, Liao Y (2011) Correlation Between HLA-DRB1, HLA-DQB1 Polymorphism and Autoantibodies Against Angiotensin AT1 Receptors in Chinese Patients With Essential Hypertension. Clin Cardiol 34:302\u2013308. https:\/\/doi.org\/10.1002\/clc.20852","journal-title":"Clin Cardiol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06055-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:06:23Z","timestamp":1697630783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06055-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6055"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06055-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board at University of California, Los Angeles (UCLA) approved this study (IRB#21\u2013000932) and this study conforms with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards and the Principles of the Declaration of Istanbul.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent for data use for research purposes has been completed by the investigators of prior studies (IRB#12\u2013001231, IRB#12\u2013001407, IRB#11\u2013002792, and IRB#16\u2013000777).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no non-financial interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}